ArticleEuropean urology2017

Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.

James J Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.